Therapeutic approach to treat virus-induced lung failure for severe COVID-19 shows promise in clinical trial
byUniversity of CologneKaplan–Meier cumulative rate and its 95% confidence interval for the time to clinical improvement. SOC, standard of care. Credit:eClinicalMedicine(2024). DOI:
Updated on: December 03,2024
Therapeutic approach to treat virus-induced lung failure for severe COVID-19 shows promise in clinical trial
byUniversity of CologneKaplan–Meier cumulative rate and its 95% confidence interval for the time to clinical improvement. SOC, standard of care. Credit:eClinicalMedicine(2024). DOI:
Updated on:December 03,2024
